Queensland Drug Trends 2016: Findings from the Illicit Drug Reporting System (IDRS)
Fairlie McIlwraith, Salom, Caroline, Rosa Alati
Abstract
Open-access reader
Fairlie McIlwraith, Salom, Caroline, Rosa Alati
Abstract
Open-access reader
Recent use of illicit (non-prescribed) OSTs was buprenorphine 24%, methadone liquid 18%, buprenorphine-naloxone 12%, and methadone tablets 2%.Over one third (36%) reported recent morphine use, and a quarter (25%) reported recent oxycodone use: use of both was predominantly illicit.Recent use of fentanyl was reported by 15%, non-medicinal over-the-counter codeine by 26%, and other opiates (e.g.Panadeine Forte®) by 20%. Unfair treatmentThe majority of respondents reported some level of unfair treatment in the previous 12 months, most commonly by the police and when getting help for physical health problems.xii
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Recent use of illicit (non-prescribed) OSTs was buprenorphine 24%, methadone liquid 18%, buprenorphine-naloxone 12%, and methadone tablets 2%.Over one third (36%) reported recent morphine use, and a quarter (25%) reported recent oxycodone use: use of both was predominantly illicit.Recent use of fentanyl was reported by 15%, non-medicinal over-the-counter codeine by 26%, and other opiates (e.g.Panadeine Forte®) by 20%. Unfair treatmentThe majority of respondents reported some level of unfair treatment in the previous 12 months, most commonly by the police and when getting help for physical health problems.xii
Key concepts: Illicit drug, Drug, Business, Medicine, Environmental health, Pharmacology